@文章{信息:doi/10.2196/40877，作者=" saaig {\'i}-Rubi{\'o}， Francesc和Borges do Nascimento, Israel J{\' i}和Robles, Noem{\'i}和Ivanovska, Keti和Katz, Che和azzopardii - muscat, Natasha和Novillo Ortiz, David"，标题="世界卫生组织欧洲区域远程医疗技术使用现状:，期刊="J Med Internet Res"，年="2022"，月="10"，日="27"，卷="24"，号="10"，页数="e40877"，关键词="远程医疗";欧洲;世界卫生组织;背景:近年来，世界卫生组织(世卫组织)欧洲区域的53个成员国开展了几项系统综述，评估临床医生、患者和卫生当局使用远程医疗来改善医疗服务。然而，尚未进行一项总结这些综述结果的研究。目的:本系统综述旨在总结53个成员国使用远程医疗的调查结果，并确定远程医疗的有效性、可行性和适用性已得到证明的医疗领域和护理水平。还评估和整理了远程医疗使用的障碍和促进因素，以帮助远程医疗干预措施的设计和实施。方法:通过对已发表和未发表的文献进行全面系统评价，我们从纳入研究的每一篇综述中提取临床、流行病学和技术相关数据。我们重点评估了所考虑的53个成员国中远程医疗应用程序使用的障碍和促进因素。 We rated the methodological quality of each of the included reviews based on A Measurement Tool to Assess Systematic Review 2 approach and judged the overall certainty of evidence by using the Grading of Recommendations, Assessment, Development, and Evaluations methodology. The entire process was performed by 2 independent authors. Results: This overview drew on data from >2239 primary studies, with >20,000 enrolled patients in total, within the WHO European Region. On the basis of data from randomized trials, observational studies, and economic evaluations from several countries, the results show a clear benefit of telemedicine technologies in the screening, diagnosis, management, treatment, and long-term follow-up of a series of chronic diseases. However, we were unable to pool the results into a reliable numeric parameter because of the high heterogeneity of intervention methodologies, scheduling, primary study design discrepancies, settings, and geographical locations. In addition to the clinical outcomes of the interventions, the social and economic outcomes are highlighted. Conclusions: The application of telemedicine is well established across countries in the WHO European Region; however, some countries could still benefit from the many uses of these digital solutions. Barriers related to users, technology, and infrastructure were the largest. Conversely, the provision of health services using technological devices was found to significantly enhance patients' clinical outcomes, improve the long-term follow-up of patients by medical professionals, and offer logistical benefits for both patients and health workers. Trial Registration: PROSPERO (International Prospective Register of Systematic Reviews) CRD42022309375; https://www.crd.york.ac.uk/prospero/display{\_}record.php?RecordID=309375 ", issn="1438-8871", doi="10.2196/40877", url="//www.mybigtv.com/2022/10/e40877", url="https://doi.org/10.2196/40877", url="http://www.ncbi.nlm.nih.gov/pubmed/3" }